Tetrahydrofuran → HCID 86705120, compound
Reaction equation
[C:1](Cl)(=[O:6])[CH2:2][CH:3]([CH3:5])[CH3:4].[C:8]([C:11]1[CH:12]=[C:13]([C:16]([NH:18][N:19]([CH2:35][C@@H:36]([OH:40])[C:37]([OH:39])=[O:38])[CH2:20][C:21]2[CH:26]=[CH:25][C:24]([C:27]3[CH:32]=[C:31]([Cl:33])[CH:30]=[CH:29][C:28]=3[F:34])=[CH:23][CH:22]=2)=[O:17])[NH:14][N:15]=1)(=[O:10])[CH3:9].C1COCC1>>[C:8]([C:11]1[CH:12]=[C:13]([C:16]([NH:18][N:19]([CH2:35][C@@H:36]([O:40][C:1](=[O:6])[CH2:2][CH:3]([CH3:5])[CH3:4])[C:37]([OH:39])=[O:38])[CH2:20][C:21]2[CH:26]=[CH:25][C:24]([C:27]3[CH:32]=[C:31]([Cl:33])[CH:30]=[CH:29][C:28]=3[F:34])=[CH:23][CH:22]=2)=[O:17])[NH:14][N:15]=1)(=[O:10])[CH3:9]Participants
4
Procedure
Isovaleryl chloride (51.4 μL, 421.2 μmol) and (R)-3-[N′-(5-acetyl-2H-pyrazole-3-carbonyl)-N-(5′-chloro-2′-fluorobiphenyl-4-ylmethyl)hydrazino]-2-hydroxypropionic acid (20.0 mg, 42.1 μmol) were combined in THF (205 μL, 2.5 mmol), and stirred overnight at room temperature. The solvent was evaporated and the residue was purified (reverse phase HPLC column) to yield the title compound (11.8 mg) as a TFA salt. MS m/z [M+H]+ calc'd for C27H28ClFN4O6, 559.17. found 559.1.
Workup
- customThe solvent was evaporated
- customthe residue was purified (reverse phase HPLC column)
Sources & evidence
- ORD record
- ord-992d504909e9414f86db29e26f33262d
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08871792B2
Reaction notes
Loading…